Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 117

Results For "AP"

6643 News Found

ANDA approval from USFDA for Unichem's Extended Phenytoin Sodium Capsules
Drug Approval | October 15, 2022

ANDA approval from USFDA for Unichem's Extended Phenytoin Sodium Capsules

Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures


Apollo launches automated AI based patient monitoring system
Digitisation | October 15, 2022

Apollo launches automated AI based patient monitoring system

This will dramatically improve timely intervention with the right experts thus ensuring significant improvement in patient’s condition management and health outcome


Roche Diagnostics and Apollo Hospitals puts spotlight on safe blood for transfusion
News | October 14, 2022

Roche Diagnostics and Apollo Hospitals puts spotlight on safe blood for transfusion

The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year


Marksans to acquire Tevapharm's bulk formulations business
News | October 12, 2022

Marksans to acquire Tevapharm's bulk formulations business

Plans to double its manufacturing footprint to bolster the growth


Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial
Diagnostic Center | October 09, 2022

Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial

Study achieves primary endpoint of radiographic progression-free survival


Pfizer acquires Global Blood Therapeutics
News | October 09, 2022

Pfizer acquires Global Blood Therapeutics

Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community


Zydus receives final approval from USFDA and 180 days shared exclusivity for Brivaracetam Tablets
Drug Approval | October 07, 2022

Zydus receives final approval from USFDA and 180 days shared exclusivity for Brivaracetam Tablets

Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.


Lupin appoints Dr. Shahin Fesharaki as Global Chief Scientific Officer
People | October 07, 2022

Lupin appoints Dr. Shahin Fesharaki as Global Chief Scientific Officer

Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.


Zydus receives USFDA tentative approval for Amantadine Extended-Release capsules
Drug Approval | October 05, 2022

Zydus receives USFDA tentative approval for Amantadine Extended-Release capsules

Amantadine Extended-Release capsules had annual sales of US $2.7 million in the United States according to IQVIA data


Granules India inaugurated water tank at Bonthapally village
News | October 05, 2022

Granules India inaugurated water tank at Bonthapally village

The two overhead tanks commissioned at a cost of Rs 57 lakh will be maintained by the village panchayats.